US gene-patent ruling could mean better cancer genetics tests for Canadians

While Canada is not directly affected by a U.S. Supreme Court decision this week that says human genes cannot be patented, it will likely result in better and faster genetic tests for Canadians down the road, says an expert on intellectual property law. Richard Gold, the director of the Centre for Intellectual Property at McGill University, says while the decision affects only researchers and biotechnology companies in the U.S., it puts Canadian patent laws into question. Read more here.